Abbott and AbbVie Named to S&P Dividend Aristocrats Indices

Mon Jan 21, 2013 10:00am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130121:nPnAQ45368




ABBOTT PARK, Ill.,  Jan. 21, 2013  /PRNewswire/ -- Abbott (NYSE: ABT) has once
again been named to the S&P 500 Dividend Aristocrats and S&P High Yield Dividend
Aristocrats Indices.  

The S&P 500 Dividend Aristocrats comprises companies in the S&P 500 that have
increased dividends every year for the past 25 consecutive years. The S&P High
Yield Dividend Aristocrats includes companies within the S&P Composite 1500 with
20 straight years of dividend increases. Abbott has increased its dividend
payout for 40 consecutive years.

Abbott's former research-based pharmaceutical business, which became the
independent biopharmaceutical company AbbVie on  Jan. 1, 2013, was also named to
both lists based on the history of the combined companies' dividend record.  

About Abbott

Abbott is a global healthcare company devoted to improving life through the
development of products and technologies that span the breadth of healthcare.
With a portfolio of leading, science-based offerings in diagnostics, medical
devices, nutritionals and branded generic pharmaceuticals, Abbott serves people
in more than 150 countries and employs approximately 70,000 people.   

Visit Abbott at  www.abbott.com  and connect with us on Twitter at @AbbottNews.



SOURCE  Abbott


Media, Scott Stoffel, +1-847-936-9502; Financial, Brian Yoor, +1-847-937-6343

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.